1265295-56-4
1265295-56-4
Chemical Structure
MRE-269-d6
Synonym(s): ACT-333679-d6
- CAS No.: 1265295-56-4
- Formula:C25H23D6N3O3
- Molecular Weight:425.55
IUPAC Name: 2-(4-((5,6-diphenylpyrazin-2-yl)(propan-2-yl-1,1,1,3,3,3-d6)amino)butoxy)acetic acid
InChIKey: OJQMKCBWYCWFPU-WFGJKAKNSA-N
SMILES: O=C(O)COCCCCN(C1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)N=C1)C(C([2H])([2H])[2H])C([2H])([2H])[2H]
Biological Activity: MRE-269-d6 is deuterium labeled MRE-269. MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MRE-269-d6 | MRE-269-d6 is deuterium labeled MRE-269. MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MRE-269 (Standard) | ≥98% | MRE-269 (Standard) is the analytical standard of MRE-269. This product is intended for research and analytical applications. MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MRE-269-d7 sodium | MRE-269-d7 (ACT-333679-d7) sodium is deuterium-labeled MRE-269 (HY-79593). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MRE-269-d7 | 99.59% | MRE-269-d7 is deuterium labeled MRE-269 (HY-79593). MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MRE-269 | 99.14% | MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
